Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.00
Ask: 67.00
Change: -0.50 (-0.76%)
Spread: 4.00 (6.349%)
Open: 65.50
High: 65.50
Low: 65.00
Prev. Close: 65.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

25 May 2006 07:04

Torex Retail PLC25 May 2006 25 May 2006 Torex Retail Plc AGM STATEMENT Torex Retail ("Torex Retail" or "the Group"), an international market leader inthe provision of innovative retail IT systems, will today hold its AnnualGeneral Meeting. Chris Moore, Chairman and Chief Executive, will make thefollowing statement on current trading: The Group has made a good start to the year enjoying sales success in all ourkey business areas and geographic markets. In addition to the £30 million of newcontracts that we secured in the first quarter, the Group has continued to winsignificant contracts with new and existing customers including McDonald's,Boots, Liz Claiborne, BT, Tesco, Walmart-Asda and the Dutch Post Office. Particularly pleasing was a contract with The Picture People, a US portraitstudio chain with over 300 outlets nationwide. This was our first new businesswin for our Lucas EPoS product from a US headquartered retailer and was achievedwithin a year of the launch of this product into the US market. The system willstart roll out in July and will be a valuable reference site for further salesprogress in the US. Integration of 2005 acquisitions has continued to plan and we have now agreedformal employment plans with our employees in Germany. As a result, plans arenow being implemented to reduce the workforce by approximately 150 employees,with restructuring costs and subsequent annualised savings in line with theoriginal estimates previously communicated to the Stock Market. In April we completed the US$55 million acquisition of Savista, whichrepresented a major strategic step in the development of our Group and itsfurther penetration of the US market. Torex Retail is now the global EPoSsupplier to McDonalds and a market leader in the Quick Service Restaurantsector, the fastest growing part of the hospitality market. We see tremendousopportunities for this business going forward both from increased sales toMcDonalds and new business wins from other international QSR chains and alsothrough indirect channel sales. Trading for the first quarter was in line with our budget and the continuedlevel of order intake gives the Board confidence that the first six months of2006 will meet expectations. As in previous years, we expect trading activity toincrease in the second six months of 2006. Based on our current order book andsales pipeline, we are confident of achieving the full year forecastexpectations currently in the Stock Market. Chris Moore, Chairman and Chief Executive of Torex Retail, commented: "I am delighted with the progress we have made this year to date. The continuingprogramme of integrating our acquisitions is delivering bottom line savings andoperating efficiencies at the same time as we continue to target top linegrowth. Last year saw us become the leading provider of retail IT systems across Europeand we believe 2006 will see us make significant steps towards becoming aleading supplier to the North American market as well as further strengtheningour market position and brand on the global stage. The continuing delivery of the company strategy is both exciting and representsfurther consolidation of delivering shareholder value". - ends - For further information please contact: Torex RetailChris Moore, Chairman and Chief Executive +44 (0)870 300 6061 Citigate Dewe RogersonGinny Pulbrook, Executive Director +44 (0)20 7282 2945Seb Hoyle, Associate Director +44 (0)20 7282 2822 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Nov 20177:00 amRNSAppointment of CEO
18th Oct 20177:00 amRNSDirectorate Change
11th Oct 20177:15 amRNSHardman Research: Dual revenue stream growth
28th Sep 20173:15 pmRNSUnaudited Interim Results
8th Sep 20177:00 amRNSNotice of Results
5th Sep 20173:52 pmRNSNotification Of Major Holdings
30th Aug 20175:15 pmRNSIssue of Equity
16th Aug 201712:22 pmRNSHolding(s) in Company
11th Aug 20173:45 pmRNSHolding(s) in Company
11th Aug 20173:37 pmRNSHolding(s) in Company
10th Aug 20174:30 pmRNSHolding(s) in Company
10th Aug 20172:45 pmRNSHolding(s) in Company
10th Aug 20171:10 pmRNSHardman Research: CellRight transforming US growth
10th Aug 201710:10 amRNSHolding(s) in Company
9th Aug 20173:00 pmRNSHolding(s) in Company
9th Aug 20172:30 pmRNSDirector/PDMR Shareholding
8th Aug 20171:41 pmRNSResults of General Meeting and Total Voting Rights
21st Jul 20176:00 pmRNSCirc re.CellRight Acquisition
21st Jul 20178:05 amRNSSuccessful fundraising of £40 million
20th Jul 20176:03 pmRNSProposed Acquisition and Placing
30th Jun 201712:00 pmRNSResult of AGM
2nd Jun 20177:00 amRNSAnnual results for period ended 31 December 2016
31st May 201710:46 amRNSPotential Acquisition Update
19th May 201711:35 amRNSPotential Acquisition
3rd Apr 20177:00 amRNSIssue of Equity
13th Mar 20177:10 amRNSHardman Research: Addressing woundcare in the US
1st Mar 20177:00 amRNSInnovative Technology Contract Awarded
2nd Feb 20177:00 amRNSDermaPure® added to the Federal Supply Schedule
6th Jan 20177:00 amRNSDirectorate Change
9th Dec 20167:15 amRNSHardman Research: a/c change: Not simply 11/12ths
7th Dec 20161:04 pmRNSTR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Dec 20167:00 amRNSDermaPure secures GPO agreement with Premier, Inc.
28th Nov 20167:05 amRNSOrthoPureT XT update
22nd Nov 20167:00 amRNSDirectorate Change
12th Oct 20167:00 amRNSInterim Results
28th Sep 20167:00 amRNSNotice of Interim Results
15th Sep 20163:07 pmRNSEdison issues outlook on Tissue Regenix
1st Sep 20167:00 amRNSDermaPure® Medicare coverage in further 10 States
3rd Aug 20167:15 amRNSHardman & Co Research Report on: Tissue Regenix
28th Jul 201610:58 amRNSEdison research outlook on Tissue Regenix (TRX)
18th Jul 201611:20 amRNSTR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
11th Jul 20167:00 amRNSOrthopaedics Update
4th Jul 201610:41 amRNSResult of AGM
1st Jul 20167:00 amRNSDermaPure® secures first GPO contract in US
30th Jun 20167:00 amRNSDeferred Annual Bonus Scheme
1st Jun 20167:00 amRNSNew appointment adds clinical expertise to Board
23rd May 20167:00 amRNSPreliminary results for year ended 31 January 2016
20th Apr 20167:00 amRNSNotice of Preliminary Results
14th Apr 20167:00 amRNSChange of Registered Office
24th Mar 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.